GAAP Financial Statements
Fortress Biotech, Inc. (FBIOP)
3 quarters · 1 annual periods · CIK 0001429260
Quarterly (3)
| Period | Form | Revenue | Gross Profit | Op. Income | Net Income | EPS (Basic) | EPS (Dil.) | Assets | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Q3 FY2025 | 10-Q | $17.6M | — | -$6.8M | $5.8M | $0.13 | $0.11 | $181.4M | $86.2M |
| Q2 FY2025 | 10-Q | $1.4M | — | -$2.9M | $15.5M | $0.50 | $0.45 | $4.2M | $74.4M |
| Q1 FY2025 | 10-Q | $2.1M | — | -$22.3M | -$10.6M | $-0.48 | $-0.48 | $34.2M | $91.3M |
Annual (1)
| Period | Form | Revenue | Gross Profit | Op. Income | Net Income | EPS (Basic) | EPS (Dil.) | Assets | Cash |
|---|---|---|---|---|---|---|---|---|---|
| FY FY2024 | 10-K | $57.7M | — | -$110.4M | -$46.0M | $-2.69 | $-2.69 | $9.3M | $57.3M |
Source: SEC EDGAR XBRL filings. Per-period figures are pulled from the original 10-Q / 10-K / 20-F submissions. Balance-sheet items (Assets, Cash, Equity) are point-in-time at period end.